UK-EDI is a research programme funded by Cancer Research UK which will explore the link between new-onset diabetes and pancreatic cancer with the aim of finding ways to diagnose pancreatic cancer earlier.
Most cases of type 2 diabetes are due to lifestyle or genetic factors. However, in approximately 1 in 100 people, a new diagnosis of type 2 diabetes could be an early warning sign of pancreatic cancer.
Through this research we hope to develop a diagnostic test for use in individuals newly diagnosed with diabetes which will identify those most at risk of pancreatic cancer, allowing them to be screened.
The aim of UK-EDI is to detect pancreatic cancer earlier.
UK-EDI consists of seven work packages that contribute to the overall aim of the programme.
UK-EDI is hosted by the University of Liverpool in collaboration with the Liverpool Clinical Trials Centre (LCTC), Liverpool GCP labs, Liverpool ECMC and the University of Strathclyde.